“Real-life” results of front-line treatment with Imatinib in older patients (?65 years) with newly diagnosed chronic myelogenous leukemia

Posted by rob on September 30, 2010 under Uncategorized | Comments are off for this article

Abstract: The age role was evaluated in 117 consecutive patients with newly diagnosed CML at our Institution treated with front-line Imatinib from 9/02 to 3/08. Forty patients (34.1%) aged ?65 years and 77 (65.9%) (Source: Leukemia Research)
More